CA2348757A1 - Polypeptides secretes et transmembranaires et acides nucleiques codant pour ceux-ci - Google Patents
Polypeptides secretes et transmembranaires et acides nucleiques codant pour ceux-ci Download PDFInfo
- Publication number
- CA2348757A1 CA2348757A1 CA002348757A CA2348757A CA2348757A1 CA 2348757 A1 CA2348757 A1 CA 2348757A1 CA 002348757 A CA002348757 A CA 002348757A CA 2348757 A CA2348757 A CA 2348757A CA 2348757 A1 CA2348757 A1 CA 2348757A1
- Authority
- CA
- Canada
- Prior art keywords
- seq
- polypeptide
- sequence identity
- amino acid
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/001—Oxidoreductases (1.) acting on the CH-CH group of donors (1.3)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Toxicology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
L'invention a trait à de nouveaux polypeptides et à des molécules d'acides nucléiques codant pour ces polypeptides. L'invention concerne également des vecteurs et des cellules hôtes contenant ces séquences d'acides nucléiques, des molécules polypeptidiques chimères contenant les polypeptides de l'invention fusionnés à des séquences polypeptidiques hétérologues, des anticorps qui se lient aux polypeptides de la présente invention et des procédés de production des polypeptides de l'invention.
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002405945A CA2405945A1 (fr) | 1998-12-16 | 1999-12-01 | Polypeptides secretes et transmembranaires et acides nucleiques codant pour ceux-ci |
CA002407803A CA2407803A1 (fr) | 1999-02-12 | 1999-12-01 | Polypeptides secretes et transmembranaires et acides nucleiques codant pour ceux-ci |
CA002406256A CA2406256A1 (fr) | 1999-01-12 | 1999-12-01 | Polypeptides secretes et transmembranaires et acides nucleiques codant pour ceux-ci |
CA002405791A CA2405791A1 (fr) | 1999-02-10 | 1999-12-01 | Polypeptides secretes et transmembrainaires et acides nucleiques codant pour ceux-ci |
Applications Claiming Priority (21)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11314598P | 1998-12-16 | 1998-12-16 | |
US11285198P | 1998-12-16 | 1998-12-16 | |
US60/112,851 | 1998-12-16 | ||
US60/113,145 | 1998-12-16 | ||
US11351198P | 1998-12-22 | 1998-12-22 | |
US60/113,511 | 1998-12-22 | ||
US11573399P | 1999-01-12 | 1999-01-12 | |
US11555899P | 1999-01-12 | 1999-01-12 | |
US11556599P | 1999-01-12 | 1999-01-12 | |
US60/115,733 | 1999-01-12 | ||
US60/115,565 | 1999-01-12 | ||
US60/115,558 | 1999-01-12 | ||
US11934199P | 1999-02-09 | 1999-02-09 | |
US60/119,341 | 1999-02-09 | ||
US11953799P | 1999-02-10 | 1999-02-10 | |
US60/119,537 | 1999-02-10 | ||
US11996599P | 1999-02-12 | 1999-02-12 | |
US60/119,965 | 1999-02-12 | ||
USPCT/US99/12252 | 1999-06-02 | ||
PCT/US1999/012252 WO1999063088A2 (fr) | 1998-06-02 | 1999-06-02 | Proteines membranaires et acides nucleiques codant ces proteines |
PCT/US1999/028634 WO2000036102A2 (fr) | 1998-12-16 | 1999-12-01 | Polypeptides secretes et transmembranaires et acides nucleiques codant pour ceux-ci |
Related Child Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002405945A Division CA2405945A1 (fr) | 1998-12-16 | 1999-12-01 | Polypeptides secretes et transmembranaires et acides nucleiques codant pour ceux-ci |
CA002405791A Division CA2405791A1 (fr) | 1999-02-10 | 1999-12-01 | Polypeptides secretes et transmembrainaires et acides nucleiques codant pour ceux-ci |
CA002407803A Division CA2407803A1 (fr) | 1999-02-12 | 1999-12-01 | Polypeptides secretes et transmembranaires et acides nucleiques codant pour ceux-ci |
CA002406256A Division CA2406256A1 (fr) | 1999-01-12 | 1999-12-01 | Polypeptides secretes et transmembranaires et acides nucleiques codant pour ceux-ci |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2348757A1 true CA2348757A1 (fr) | 2000-06-22 |
Family
ID=27578476
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002348757A Abandoned CA2348757A1 (fr) | 1998-12-16 | 1999-12-01 | Polypeptides secretes et transmembranaires et acides nucleiques codant pour ceux-ci |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1141285A2 (fr) |
JP (5) | JP2003521229A (fr) |
KR (2) | KR100468977B1 (fr) |
AU (7) | AU777006B2 (fr) |
CA (1) | CA2348757A1 (fr) |
IL (11) | IL142794A0 (fr) |
MX (1) | MXPA01006057A (fr) |
WO (1) | WO2000036102A2 (fr) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020137890A1 (en) | 1997-03-31 | 2002-09-26 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
US8088386B2 (en) | 1998-03-20 | 2012-01-03 | Genentech, Inc. | Treatment of complement-associated disorders |
US7192589B2 (en) | 1998-09-16 | 2007-03-20 | Genentech, Inc. | Treatment of inflammatory disorders with STIgMA immunoadhesins |
US8007798B2 (en) | 1997-11-21 | 2011-08-30 | Genentech, Inc. | Treatment of complement-associated disorders |
US7419663B2 (en) | 1998-03-20 | 2008-09-02 | Genentech, Inc. | Treatment of complement-associated disorders |
US6914130B2 (en) * | 1998-06-17 | 2005-07-05 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
AU2008201101B2 (en) * | 1999-03-11 | 2011-01-20 | Merck Serono Sa | Vascular adhesion molecules and modulation of their function |
EE05497B1 (et) * | 1999-03-11 | 2011-12-15 | Rmf Dictagene S.A. | Polüpeptiid, lahustuv CRAM-1 polüpeptiid, polünukleotiid ja antikeha |
KR100543857B1 (ko) * | 1999-09-01 | 2006-01-23 | 제넨테크, 인크. | 혈관신생 및 심혈관형성의 촉진 또는 억제 |
DE19947010A1 (de) * | 1999-09-30 | 2001-04-05 | Universitaetsklinikum Freiburg | Das Gen PRV-1 und dessen Verwendung |
US20020006653A1 (en) * | 2000-04-28 | 2002-01-17 | Meyers Rachel A. | 25692, a novel human O-Methyltransferase family member and uses thereof |
GB0110273D0 (en) * | 2001-04-26 | 2001-06-20 | Inpharmatica Ltd | Novel proteins |
WO2003053334A2 (fr) * | 2001-12-19 | 2003-07-03 | Genentech, Inc. | Compositions et methodes de diagnostic et de traitement de tumeur |
US20070191402A1 (en) * | 2002-05-17 | 2007-08-16 | Kyowa Hakko Kogyo Co., Ltd. | Method of searching substrate having antidiabetic activity |
JP2006501290A (ja) * | 2002-10-02 | 2006-01-12 | デヴェロゲン アクチエンゲゼルシャフト フュア エントヴィックルングスビオローギッシェ フォルシュング | エネルギー恒常性の調節に関与するMipp1相同性を有する核酸およびタンパク質 |
CN107929731A (zh) | 2005-11-04 | 2018-04-20 | 健泰科生物技术公司 | 利用补体途径抑制剂治疗眼部疾病 |
US8007797B2 (en) | 2006-09-28 | 2011-08-30 | Merck Serono S.A. | Junctional adhesion molecule-C (JAM-C) binding compounds and methods of their use |
ES2700609T3 (es) | 2006-11-02 | 2019-02-18 | Genentech Inc | Anticuerpos anti-factor D humanizados y sus usos |
AR066660A1 (es) | 2007-05-23 | 2009-09-02 | Genentech Inc | Prevencion y tratamiento de condiciones del ojo asociadas con su complemento |
CR20170001A (es) | 2008-04-28 | 2017-08-10 | Genentech Inc | Anticuerpos anti factor d humanizados |
BRPI0912003A2 (pt) | 2008-05-06 | 2016-07-12 | Genentech Inc | afinidade de variantes de crig maturadas |
KR20180021234A (ko) | 2013-08-12 | 2018-02-28 | 제넨테크, 인크. | 보체-연관 상태의 치료를 위한 조성물 및 방법 |
WO2015168468A1 (fr) | 2014-05-01 | 2015-11-05 | Genentech, Inc. | Variants d'anticorps anti-facteur d et leurs utilisations |
EP3368090A1 (fr) | 2015-10-30 | 2018-09-05 | H. Hoffnabb-La Roche Ag | Conjugués de variants d'anticorps anti-facteur d et leurs utilisations |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6001970A (en) * | 1994-11-07 | 1999-12-14 | Merck & Co., Inc | Modified human neuropeptide Y1 Receptors |
WO1997025427A1 (fr) * | 1996-01-12 | 1997-07-17 | Genetics Institute, Inc. | Beta-chemokine, h1305 (mpc-2) |
JP3646191B2 (ja) * | 1996-03-19 | 2005-05-11 | 大塚製薬株式会社 | ヒト遺伝子 |
WO1998050552A1 (fr) * | 1997-05-06 | 1998-11-12 | Zymogenetics, Inc. | Nouveaux antigenes tumoraux |
DE19818620A1 (de) * | 1998-04-21 | 1999-10-28 | Metagen Gesellschaft Fuer Genomforschung Mbh | Menschliche Nukleinsäuresequenzen aus Blase-Normal |
WO2000000610A2 (fr) * | 1998-06-26 | 2000-01-06 | Incyte Pharmaceuticals, Inc. | Proteines contenant un peptide signal humain |
WO2000004135A2 (fr) * | 1998-07-16 | 2000-01-27 | Incyte Pharmaceuticals, Inc. | Molecules apparentees a l'alcool-deshydrogenase chaine courte de type humain, scrm-1 et scrm-2 |
DE19849044A1 (de) * | 1998-10-23 | 2000-04-27 | Univ Ludwigs Albert | Das Gen PRV-1 und dessen Verwendung |
WO2000029583A2 (fr) * | 1998-11-19 | 2000-05-25 | Incyte Pharmaceuticals, Inc. | Proteines de la superfamille des immunoglobulines |
JP2004520003A (ja) * | 1999-03-08 | 2004-07-08 | ジェネンテック・インコーポレーテッド | 腫瘍治療のための組成物及び方法 |
-
1999
- 1999-12-01 WO PCT/US1999/028634 patent/WO2000036102A2/fr active Application Filing
- 1999-12-01 CA CA002348757A patent/CA2348757A1/fr not_active Abandoned
- 1999-12-01 IL IL14279499A patent/IL142794A0/xx active IP Right Grant
- 1999-12-01 KR KR10-2004-7013508A patent/KR100468977B1/ko not_active IP Right Cessation
- 1999-12-01 AU AU19320/00A patent/AU777006B2/en not_active Expired
- 1999-12-01 JP JP2000588351A patent/JP2003521229A/ja not_active Withdrawn
- 1999-12-01 EP EP99962992A patent/EP1141285A2/fr not_active Withdrawn
- 1999-12-01 MX MXPA01006057A patent/MXPA01006057A/es active IP Right Grant
- 1999-12-01 KR KR10-2001-7007461A patent/KR100468978B1/ko not_active IP Right Cessation
-
2001
- 2001-04-25 IL IL142794A patent/IL142794A/en not_active IP Right Cessation
-
2003
- 2003-08-14 JP JP2003293650A patent/JP2004041217A/ja not_active Withdrawn
- 2003-08-14 JP JP2003293651A patent/JP2004041218A/ja not_active Withdrawn
-
2004
- 2004-12-10 AU AU2004237842A patent/AU2004237842B2/en not_active Expired
- 2004-12-14 AU AU2004237920A patent/AU2004237920B2/en not_active Expired
- 2004-12-14 AU AU2004237923A patent/AU2004237923B2/en not_active Expired
- 2004-12-14 AU AU2004237922A patent/AU2004237922B2/en not_active Expired
- 2004-12-14 AU AU2004237919A patent/AU2004237919B2/en not_active Expired
- 2004-12-14 AU AU2004237921A patent/AU2004237921B2/en not_active Expired
-
2006
- 2006-10-17 JP JP2006282251A patent/JP2007075118A/ja not_active Withdrawn
-
2007
- 2007-06-13 JP JP2007156006A patent/JP2007312779A/ja not_active Withdrawn
-
2008
- 2008-01-03 IL IL188579A patent/IL188579A0/en unknown
- 2008-01-03 IL IL188578A patent/IL188578A0/en unknown
- 2008-01-03 IL IL188580A patent/IL188580A0/en unknown
- 2008-01-03 IL IL188581A patent/IL188581A0/en unknown
- 2008-01-03 IL IL188577A patent/IL188577A0/en unknown
- 2008-01-03 IL IL188576A patent/IL188576A0/en unknown
-
2009
- 2009-09-13 IL IL200883A patent/IL200883A0/en unknown
- 2009-09-17 IL IL201030A patent/IL201030A0/en unknown
- 2009-09-17 IL IL201001A patent/IL201001A0/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2004237920B2 (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
US20090142800A1 (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
EP1283215B1 (fr) | Polypeptide sécrété ainsi que les acides nucléiques le codant | |
EP1277833B1 (fr) | Gène amplifié dans des tumeurs et matériaux et méthodes associées | |
EP1251173B1 (fr) | Polypeptides sécrétés et transmembranaires ainsi que les acides nucléiques codant pour ceux-ci | |
CA2406256A1 (fr) | Polypeptides secretes et transmembranaires et acides nucleiques codant pour ceux-ci | |
NZ529540A (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
NZ536887A (en) | PRO 1800 polypeptides and diagonistic methods and treatment of neoplastic diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Discontinued |